恶性肿瘤中双硫死亡的新动向和未来展望

王腾飞; 陈乾; 左石

doi:10.7619/jcmp.20232477

恶性肿瘤中双硫死亡的新动向和未来展望

王腾飞^{1, 2},
陈乾³,
左石^2, ,

1.
贵州医科大学临床医学院, 贵州贵阳, 550000
2.
贵州医科大学附属医院肝胆外科, 贵州贵阳, 550000
3.
贵州医科大学附属医院器官移植科, 贵州贵阳, 550000

基金项目:

国家自然科学基金资助项目 82260535

详细信息

通讯作者:
左石, E-mail: drzuoshi@qq.com

中图分类号: R602;R73.3
计量
- 文章访问数: 436
- HTML全文浏览量: 118
- PDF下载量: 71
出版历程
- 收稿日期: 2023-08-02
- 修回日期: 2023-08-23
- 网络出版日期: 2023-09-18
- 刊出日期: 2023-09-14

New development and future prospects of disulfidptosis in malignant tumors

WANG Tengfei^{1, 2},
CHEN Qian³,
ZUO Shi^2, ,

1.
Clinical Medical College of Guizhou Medical University, Guiyang, Guizhou, 550000
2.
Department of Hepatobiliary Surgery, the Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, 550000
3.
Department of Organ Transplantation, the Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, 550000

摘要

摘要:
双硫死亡是恶性肿瘤的一种新的细胞死亡方式。细胞死亡方式包括坏死性凋亡、细胞凋亡、细胞焦亡和铁死亡、铜死亡等多种调节性细胞死亡和意外性细胞死亡。双硫死亡是当溶质载体家族7成员11(SLC7A11)蛋白高表达的细胞遭受葡萄糖饥饿时触发细胞发生死亡的一种新的细胞死亡机制。针对调节细胞死亡机制的鉴定和表征不仅能够促进人们对细胞稳态的基本理解, 而且能为治疗恶性肿瘤提供重要思路。
- 恶性肿瘤 /
- 双硫死亡 /
- 发病机制 /
- 细胞死亡机制
Abstract:
Disulfidptosis is a new cell death mode in malignant tumors. Cell death has evolved from multiple regulatory cell death and accidental cell death, including apoptosis, cellular pyroptosis, necroptosis, and iron and copper death. Disulfidptosis is a new cell death mechanism that triggers cells to undergo cell death when cells with high expression of the solute carrier family 7 member 11(SLC7A11) protein are subjected to glucose starvation. The identification and characterization of mechanisms targeting the regulation of cell death not only promotes a fundamental understanding of cellular homeostasis, but also provides important ideas for the treatment of malignant tumors.
- malignant tumor /
- disulfidptosis /
- pathogenesis /
- cell death mechanism

HTML全文

参考文献(28)

[1]	DE VISSER K E, JOYCE J A. The evolving tumor microenvironment: from cancer initiation to metastatic outgrowth[J]. Cancer Cell, 2023, 41(3): 374-403. doi: 10.1016/j.ccell.2023.02.016
[2]	WONG-ROLLE A, WEI H K, ZHAO C, et al. Unexpected guests in the tumor microenvironment: microbiome in cancer[J]. Protein Cell, 2021, 12(5): 426-435. doi: 10.1007/s13238-020-00813-8
[3]	FEINBERG A P, LEVCHENKO A. Epigenetics as a mediator of plasticity in cancer[J]. Science, 2023, 379(6632): eaaw3835. doi: 10.1126/science.aaw3835
[4]	LIU X G, NIE L T, ZHANG Y L, et al. Actin cytoskeleton vulnerability to disulfide stress mediates disulfidptosis[J]. Nat Cell Biol, 2023, 25(3): 404-414. doi: 10.1038/s41556-023-01091-2
[5]	HANAHAN D, MONJE M. Cancer hallmarks intersect with neuroscience in the tumor microenvironment[J]. Cancer Cell, 2023, 41(3): 573-580. doi: 10.1016/j.ccell.2023.02.012
[6]	YANG L, LI A T, WANG Y, et al. Intratumoral microbiota: roles in cancer initiation, development and therapeutic efficacy[J]. Signal Transduct Target Ther, 2023, 8(1): 35. doi: 10.1038/s41392-022-01304-4
[7]	WU Q H, YOU L, NEPOVIMOVA E, et al. Hypoxia-inducible factors: master regulators of hypoxic tumor immune escape[J]. J Hematol Oncol, 2022, 15(1): 77. doi: 10.1186/s13045-022-01292-6
[8]	王郑林, 汤杰, 陈佳伟, 等. 肿瘤坏死因子-α在恶性肿瘤中的作用及意义[J]. 实用临床医药杂志, 2023, 27(4): 138-143. doi: 10.7619/jcmp.20223338
[9]	THONART P, SUMBU Z L, BECHET J. Patulin degradation in Saccharomyces cerevisiae: sensitive mutants[J]. Mycotoxin Res, 1985, 1(1): 37-40. doi: 10.1007/BF03191953
[10]	MASCHALIDI S, MEHROTRA P, KEÇELI B N, et al. Targeting SLC7A11 improves efferocytosis by dendritic cells and wound healing in diabetes[J]. Nature, 2022, 606(7915): 776-784. doi: 10.1038/s41586-022-04754-6
[11]	LIN W Y, WANG C Q, LIU G P, et al. SLC7A11/xCT in cancer: biological functions and therapeutic implications[J]. Am J Cancer Res, 2020, 10(10): 3106-3126.
[12]	CHEN Q P, ZHENG W, GUAN J, et al. SOCS2-enhanced ubiquitination of SLC7A11 promotes ferroptosis and radiosensitization in hepatocellular carcinoma[J]. Cell Death Differ, 2023, 30(1): 137-151. doi: 10.1038/s41418-022-01051-7
[13]	ZHANG W J, SUN Y, BAI L, et al. RBMS1 regulates lung cancer ferroptosis through translational control of SLC7A11[J]. J Clin Invest, 2021, 131(22): e152067. doi: 10.1172/JCI152067
[14]	YANG J J, ZHOU Y L, XIE S D, et al. Metformin induces Ferroptosis by inhibiting UFMylation of SLC7A11 in breast cancer[J]. J Exp Clin Cancer Res, 2021, 40(1): 206. doi: 10.1186/s13046-021-02012-7
[15]	ALDINI G, ALTOMARE A, BARON G, et al. N-Acetylcysteine as an antioxidant and disulphide breaking agent: the reasons why[J]. Free Radic Res, 2018, 52(7): 751-762. doi: 10.1080/10715762.2018.1468564
[16]	YAN S Z, HU K M, CHEN S, et al. Photo-induced stress relaxation in reconfigurable disulfide-crosslinked supramolecular films visualized by dynamic wrinkling[J]. Nat Commun, 2022, 13(1): 7434. doi: 10.1038/s41467-022-35271-9
[17]	GHEZZI P, BONETTO V, FRATELLI M. Thiol-disulfide balance: from the concept of oxidative stress to that of redox regulation[J]. Antioxid Redox Signal, 2005, 7(7/8): 964-972.
[18]	MILLER W P, SHA C M, SUNILKUMAR S, et al. Activation of disulfide redox switch in REDD1 promotes oxidative stress under hyperglycemic conditions[J]. Diabetes, 2022, 71(12): 2764-2776. doi: 10.2337/db22-0355
[19]	WANG X B, CHEN Y Q, WANG X D, et al. Stem cell factor SOX2 confers ferroptosis resistance in lung cancer via upregulation of SLC7A11[J]. Cancer Res, 2021, 81(20): 5217-5229. doi: 10.1158/0008-5472.CAN-21-0567
[20]	FANG X X, CAI Z X, WANG H, et al. Loss of cardiac ferritin H facilitates cardiomyopathy via Slc7a11-mediated ferroptosis[J]. Circ Res, 2020, 127(4): 486-501. doi: 10.1161/CIRCRESAHA.120.316509
[21]	DEWANE G, SALVI A M, DEMALI K A. Fueling the cytoskeleton-links between cell metabolism and actin remodeling[J]. J Cell Sci, 2021, 134(3): 248385. doi: 10.1242/jcs.248385
[22]	LIU X G, ZHANG Y L, ZHUANG L, et al. NADPH debt drives redox bankruptcy: SLC7A11/xCT-mediated cystine uptake as a double-edged sword in cellular redox regulation[J]. Genes Dis, 2021, 8(6): 731-745. doi: 10.1016/j.gendis.2020.11.010
[23]	KOPPULA P, ZHUANG L, GAN B Y. Cystine transporter SLC7A11/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy[J]. Protein Cell, 2021, 12(8): 599-620. doi: 10.1007/s13238-020-00789-5
[24]	MEYER Y, BELIN C, DELORME-HINOUX V, et al. Thioredoxin and glutaredoxin systems in plants: molecular mechanisms, crosstalks, and functional significance[J]. Antioxid Redox Signal, 2012, 17(8): 1124-1160. doi: 10.1089/ars.2011.4327
[25]	JI P Y, LI Z Y, WANG H, et al. Arsenic and sulfur dioxide co-exposure induce renal injury via activation of the NF-κB and caspase signaling pathway[J]. Chemosphere, 2019, 224: 280-288. doi: 10.1016/j.chemosphere.2019.02.111
[26]	MACHESKY L M. Deadly actin collapse by disulfidptosis[J]. Nat Cell Biol, 2023, 25(3): 375-376. doi: 10.1038/s41556-023-01100-4
[27]	ZHENG P, ZHOU C, DING Y, et al. Disulfidptosis: a new target for metabolic cancer therapy[J]. J Exp Clin Cancer Res, 2023, 42(1): 103. doi: 10.1186/s13046-023-02675-4
[28]	ODURO P K, ZHENG X X, WEI J N, et al. The cGAS-STING signaling in cardiovascular and metabolic diseases: future novel target option for pharmacotherapy[J]. Acta Pharm Sin B, 2022, 12(1): 50-75. doi: 10.1016/j.apsb.2021.05.011